Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2009 Physicians' Duty to Be Aware of and Report Environmental Toxins, Commentary 1 Gina M. Solomon, MD, MPH The physician’s duty extends beyond treating individual patients to reporting public health threats when they are identified. Virtual Mentor. 2009;11(6):434-437. doi: 10.1001/virtualmentor.2009.11.6.ccas2-0906. Case and Commentary Jun 2009 Physicians' Duty to Be Aware of and Report Environmental Toxins, Commentary 2 Steven R. Kirkhorn, MD, MPH The physician’s duty extends beyond treating individual patients to reporting public health threats when they are identified. Virtual Mentor. 2009;11(6):437-442. doi: 10.1001/virtualmentor.2009.11.6.ccas2-0906. Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408. Pagination First page « First Previous page ‹ Previous … Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Current page 14
Case and Commentary Jun 2009 Physicians' Duty to Be Aware of and Report Environmental Toxins, Commentary 1 Gina M. Solomon, MD, MPH The physician’s duty extends beyond treating individual patients to reporting public health threats when they are identified. Virtual Mentor. 2009;11(6):434-437. doi: 10.1001/virtualmentor.2009.11.6.ccas2-0906.
Case and Commentary Jun 2009 Physicians' Duty to Be Aware of and Report Environmental Toxins, Commentary 2 Steven R. Kirkhorn, MD, MPH The physician’s duty extends beyond treating individual patients to reporting public health threats when they are identified. Virtual Mentor. 2009;11(6):437-442. doi: 10.1001/virtualmentor.2009.11.6.ccas2-0906.
Medicine and Society Aug 2004 Presymptomatic Genetic Testing for Neurodegenerative Diseases Shane K. Green, PhD Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly. Virtual Mentor. 2004;6(8):360-363. doi: 10.1001/virtualmentor.2004.6.8.msoc1-0408.